Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

Share Price is delayed by 15 minutes
Get Live Data
849.50    -28.50 (-3.25%)
Bid:
852.50
Ask:
854.50
Spread: 2.00 (0.235%)
Market Cap: £978.40m
KNOS Live PriceLast checked at - London Stock Exchange

Intraday Kainos Group Share Chart

Trading Statement

1 Sep 2025 07:00

RNS Number : 2956X
Kainos Group plc
01 September 2025
 

01 September 2025

Kainos Group plc

("Kainos" or the "Company")

 

H1 Scheduled Trading Update

 

Kainos Group plc (KNOS), a UK-headquartered IT provider with expertise across three divisions, Digital Services, Workday Services, and Workday Products, today issues its customary trading update for the period from 1 April 2025 to date.

 

Building on our solid Q4 2025 performance, we delivered further sequential improvement in the period. As a result, the Board now expects revenues for the year ending 31 March 2026 at the upper end of consensus forecasts*, driven by stronger sales in the period. This sales success is creating opportunities for further operating progress during the rest of the financial year.

With new projects mobilising across all three divisions, we are recruiting additional staff, as well as increasing our short-term use of contractors to support both growth and our strong pipeline. We are maintaining a prudent outlook and anticipate delivering Adjusted PBT in line with current consensus forecasts*.

 

Divisional Highlights and Outlook

· Our Workday Products division has continued to deliver strong growth, passing the $100m Annual Recurring Revenue milestone in July. We are working with design partners including Diageo and Linklaters on our next product, Pay Transparency. It will launch in Q3 to support customers responding to the EU Pay Transparency Directive, which comes into force in June 2026.

 

· Within Digital Services, we have secured several significant programmes in both healthcare and the public sector, including contracts in the Home Office, NHS England, and the Driver and Vehicle Standards Agency. These engagements are expected to lead to meaningful increases in revenues for both sectors in the second half of the financial year. Strong revenue growth in North America continued, offset by performance in the commercial sector, where activity remained muted and below prior-year levels.

 

· A strong sales performance in our Workday Services division will result in a return to growth during the year, driven by improved results in our core European and North American markets as well as further progress in Australia, New Zealand and Mexico.

 

Our long-term customer relationships, combined with the commitment of our people, continue to drive valuable outcomes. We remain grateful for the trust our customers place in us and for the energy and talent of our colleagues.

 

Although the macro-economic environment has improved, volatility persists, and we continue to balance growth, international expansion, investment and profitability against this backdrop.

 

Kainos continues to operate in markets with clear long-term structural drivers, including the emerging opportunities from wider AI adoption. We remain confident in our strategy to capture and deliver on these opportunities. Backed by a robust backlog, healthy pipeline, solid balance sheet, disciplined capital allocation, and strong cash flow, we have a firm foundation from which to drive long-term shareholder value.

 

We will announce results for the six months ending 30 September 2025 on 10 November 2025.

 

* Note: Company compiled range is based on known sell side analyst estimates. The ranges are: Revenue £378.0m - £393.4m and Adjusted PBT £65.1m - £74.7m. The respective consensus figures are £385.0m and £66.4m.

 

Kainos Group plc Legal Entity Identifier: 213800H2PQMIF3OVZY47

 

Ends

 

For further information, please contact:

 

Kainos via FTI Consulting LLP

Brendan Mooney, Chief Executive Officer

Richard McCann, Chief Financial Officer

 

Investec Bank plc +44 20 7597 5970

Patrick Robb / Ben Griffiths / Nick Prowting

 

FTI Consulting LLP +44 20 3727 1000

Matt Dixon / Dwight Burden / Kwaku Aning

 

About Kainos

Kainos Group plc is a UK-headquartered provider of sophisticated IT services to major public sector, commercial and healthcare customers. Our expertise spans three divisions: Digital Services, Workday Services, and Workday Products.

 

Digital Services: We develop and support custom digital service platforms that transform service delivery in public, commercial, and healthcare sectors. Our solutions ensure security, accessibility, cost-effectiveness, and improved user outcomes.

 

Workday Services: Specialising in deploying Workday, Inc.'s Finance, HR, and Planning products, we are a respected partner in Europe and North America. Experienced in complex deployments, we are trusted to launch, test, expand, and support Workday systems.

 

Workday Products: Our established product suite, incorporating Smart Test, Smart Audit, and Smart Shield, complements Workday by enhancing system security and compliance. Our Employee Document Management product, launched in October 2023, improves document generation and storage within Workday while supporting global compliance requirements. Over 450 global customers use one or more of our products.

 

Our people are central to our success. We have more than 2,800 people in 20 countries across Europe, Asia, and the Americas.

 

We are listed on the London Stock Exchange (LSE: KNOS) and you can discover more about us at www.kainos.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSEEFDUEISESA
Date   Source Headline
15th Nov 20247:00 amRNSTransaction in Own Shares
13th Nov 20247:00 amRNSTransaction in Own Shares
12th Nov 202412:32 pmRNSDirector / PDMR shareholdings
11th Nov 20247:01 amRNSShare buyback programme
11th Nov 20247:00 amRNSInterim Results
31st Oct 20247:00 amRNSTrading Update
1st Oct 20249:49 amRNSTotal Voting Rights
24th Sep 20241:11 pmRNSBoard Changes
24th Sep 20241:06 pmRNSResults of Annual General Meeting
9th Sep 202410:14 amRNSHolding(s) in Company
2nd Sep 202411:13 amRNSTotal Voting Rights
2nd Sep 20247:00 amRNSTrading Statement
15th Aug 202410:00 amRNSNotice of AGM
1st Aug 202410:34 amRNSTotal Voting Rights
31st Jul 20244:41 pmRNSAnnual Report 2024
25th Jul 20242:30 pmRNSWorkday Partnership & Co-Sell drives £200m Target
11th Jul 202410:26 amRNSTR-1: Notification of major holdings
2nd Jul 20249:57 amRNSDirector / PDMR shareholdings
1st Jul 20249:23 amRNSTotal Voting Rights
3rd Jun 20243:53 pmRNSDirector/PDMR Shareholding
3rd Jun 202410:36 amRNSTotal Voting Rights
20th May 20247:01 amRNSBoard and Board Committee Changes
20th May 20247:00 amRNSFull year results
1st May 202412:00 pmRNSTotal Voting Rights
15th Apr 20247:00 amRNSYear-end Trading Update
11th Apr 20243:50 pmRNSHolding(s) in Company
2nd Apr 202412:12 pmRNSTotal Voting Rights
15th Mar 20241:48 pmRNSHolding(s) in Company
28th Feb 20243:16 pmRNSHolding(s) in Company
5th Feb 202412:51 pmRNSHolding(s) in Company
1st Feb 20244:29 pmRNSHolding(s) in Company
1st Feb 20244:21 pmRNSHolding(s) in Company
1st Feb 202412:13 pmRNSTotal Voting Rights
31st Jan 20244:09 pmRNSDirector/PDMR Shareholding
2nd Jan 202412:15 pmRNSTotal Voting Rights
22nd Dec 20239:21 amRNSExecutive Director PSP Award/PDMR shareholdings
1st Dec 20239:35 amRNSTotal Voting Rights
17th Nov 202311:13 amRNSExecutive Director PSP Award/PDMR shareholdings
13th Nov 20237:00 amRNSInterim Results
1st Nov 202310:48 amRNSTotal Voting Rights
2nd Oct 202312:41 pmRNSTotal Voting Rights
2nd Oct 20237:00 amRNSConfirmation of Board Changes
27th Sep 20235:52 pmRNSDirector/PDMR Shareholding
21st Sep 20232:54 pmRNSResults of Annual General Meeting
21st Sep 202311:59 amRNSConfirmation of CEO appointment
1st Sep 202312:34 pmRNSTotal Voting Rights
31st Aug 20237:00 amRNSTrading Update
10th Aug 20232:48 pmRNSNotice of AGM
3rd Aug 202310:41 amRNSMount Charles & Bankmore Square, Belfast
1st Aug 20234:02 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.